Related Articles
Immunotherapy in malignant peritoneal mesothelioma (Review)
Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma
Current progress of anti‑PD‑1/PDL1 immunotherapy for glioblastoma (Review)
Biomarkers for evaluating the clinical response to immune checkpoint inhibitors in renal cell carcinoma (Review)
Biomarkers of immunotherapy in non‑small cell lung cancer (Review)